Renal, hematologic and infectious complications in multiple myeloma

Best Practice and Research: Clinical Haematology

Volumn 18, Issue 4 SPEC. ISS., 2005, Pages 635-652

  Bladé, Joan ^a   Rosiñol, Laura ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Anemia; Erythropoietin; Infection; Multiple myeloma; Renal failure

Indexed keywords

ALKYLATING AGENT; AMIKACIN; CALCIUM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; HEPARIN; IMMUNOGLOBULIN; IRON; IRON SACCHARATE; LEVOFLOXACIN; MACROLIDE; MELPHALAN; METHYLPREDNISOLONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN; THALIDOMIDE; VINCRISTINE;

ACUTE LEUKEMIA; ANEMIA; AUTOTRANSPLANTATION; BLEEDING DISORDER; BONE MARROW SUPPRESSION; CALCIUM BLOOD LEVEL; CANCER RELAPSE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DIALYSIS; DRUG HALF LIFE; DRUG MEGADOSE; GRANULOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; NEUTROPENIA; PANCYTOPENIA; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STREPTOCOCCUS INFECTION; THROMBOCYTOPENIA;

EID: 22144499583     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2005.01.013     Document Type: Review

References (90)

1. R.A. DeFronzo R.L. Humphrey J.R. Wright & C.R. Cooke Acute renal failure in multiple myeloma Medicine (Baltimore) 54 1975 209-223
2. R.A. Kyle Multiple myeloma: Review of 869 cases Mayo Clin Proc 50 1975 29-40
3. S.P. Bersntein & H.D. Humes Reversible renal insufficiency in multiple myeloma Arch Intern Med 142 1982 2083-2086
4. D.J. Cohen W. Sherman E.F. Osserman & G.B. Appel Acute renal failure in patients with multiple myeloma Am J Med 76 1984 247-256
5. R. Alexanian B. Barlogie & D. Dixon Renal failure in multiple myeloma: Pathogenesis and prognostic implications Arch Intern Med 150 1990 1693-1695
6. J. Bladé P. Fernández-Llama F. Bosch et al. Renal failure in multiple myeloma. Presenting features and predictors of outcome in 94 patients from a single institution Arch Intern Med 158 1998 1889-1893
7. J. Bladé L. Rosiñol Management of myeloma patients with renal failure in: G. Gharton B.G.M. Durie & D. Samson (Eds.) Multiple Myeloma and Related Disorders 2004 Arnold London 339-349
8. J. Bladé Management of renal, hematologic, and infectious complications in: J.S. Malpas D.E. Bergsagel R.A. Kyle & K.C. Anderson (Eds.) Myeloma: Biology and Management 3rd edn 2004 Saunders Philadelphia, PA 251-267
9. L.M. Knudsen E. Hippe M. Hjorth et al. Renal function in newly diagnosed multiple myeloma. A demographic study of 1353 patients Eur J Haematol 53 1994 207-212
10. L.M. Knudsen M. Hjorth & E. Hippe Renal failure in multiple myeloma: reversibility and impact on prognosis Eur J Haematol 65 2000 175-181
11. R. Torra J. Bladé A. Cases et al. Patients with multiple myeloma and renal failure requiring long-term dialysis: Presenting features, response to therapy, and outcome in a series of 20 cases Br J Haematol 91 1995 854-859
12. W.J. Johnson R.A. Kyle A.A. Pineda et al. Treatment of renal failure associated to multiple myeloma Arch Intern Med 150 1990 863-869
13. P. Verroest L. Morel-Maroger & J.L. Preudhomme Renal lesions in dysproteinemia Semin Immunopthol 5 1982 333-356
14. C.S. Hill L. Morel-Maroger J.P. Méry et al. Renal lesions in multiple myeloma: Their relationship to associated protein abnormalities Am J Kid Dis 4 1983 423-438
15. P.W. Sanders Pathogenesis and treatment of myeloma kidney J Lab Clin Med 124 1994 484-488
16. F. Boege M. Merkle E. Werle & H. Rückle Structural features related to the nephropathogenicity of Bence Jones protein Kidney Int 46 1994 S93-S96
17. C. Pozzi S. Pasquali U. Donini et al. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: Review of 50 cases Clin Nephrol 28 1987 1-9
18. S. Rota B. Mougenot B. Baudouin et al. Multiple myeloma and severe renal failure: A clinicopathologic study of outcome and prognosis in 34 patients Medicine 66 1987 126-137
19. P. Pasqualli S. Casanova A. Zuchelli & P. Zuchelli Long-term survival in patients with acute and severe renal failure due to multiple myeloma Clin Nephrol 34 1990 247-254
20. R.A. Coward I.W. Delamore N.P. Mallick & E.L. Robinson The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma Clin Sci 66 1984 229-232
21. C. Melcion B. Mougenot B. Baudouin et al. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains Clin Nephrol 22 1984 138-143
22. R.A. Kyle & P.R. Greipp 'Idiopathic' Bence Jones proteinuria: long-term follow-up in seven patients N Engl J Med 306 1982 564-567
23. C. Montagut F. Bosch L. Villela et al. Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide Leuk Lymph 45 2004 1711-1712
24. J. Bladé J.A. Lust & R.A. Kyle Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases J Clin Oncol 12 1994 2398-2404
25. R.E. Randall W.C. Williamson F. Mullinax et al. Manifestations of systemic light chain deposition Am J Med 60 1976 293-299
26. J.L. Preudhomme P. Aucouturier G. Touchard et al Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains Kidney Int 46 1994 965-972
27. M.V. Dhodapkar G. Merlini & A. Solomon Biology and therapy of immunoglobulin deposition diseases Hemat Oncol Clin North Am 11 1997 89-110
28. C.X. Ma M.Q. Lacy J.F. Rompala et al. Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma Blood 104 2004 40-42
29. Medical Research Council Working Party on Leukemia in Adults Analysis and management of renal failure in the fourth myelomatosis trial Br Med J 288 1984 1411-1416
30. M. Cavo M. Baccarani P. Galieni et al. Renal failure in multiple myeloma: A study of the presenting findings, response to treatment and prognosis in 26 patients Nou Rev Fr Hematol 28 1986 147-152
31. R. Misiani G. Tiraboschi G. Mingardi & G. Mecca Management of myeloma kidney: An anti-light chain approach Am J Kid Dis 10 1987 28-33
32. N. Iggo A.B.D. Palmer A. Severn et al. Chronic dialysis in patients with multiple myeloma and renal failure: A worthwhile treatment Q J Med 270 1989 903-910
33. A. Korzets F. Tam G. Russell et al. The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma Am J Kid Dis 6 1990 216-223
34. B. Barlogie L. Smith & R. Alexanian Effective treatment of advanced myelom refractory to alkylating agents N Engl J Med 310 1984 1353-1356
35. R.G. Aitchison I.A.G. Reilly A.G. Morgan & N.H. Rusell Vincristine, adriamycin and high-dose steroids in myeloma complicated by renal failure Br J Cancer 61 1990 765-766
36. J.F. San Miguel J.J. Lahuerta R. García-Sanz et al. Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J 1 2000 28-36
37. A. Badros B. Barlogie E. Siegel et al. Results of autologous stem cell transplant in multiple myeloma with renal failure Br J Haematol 114 2001 822-829
38. C.K. Lee M. Zangari B. Barlogie et al. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant Bone Marrow Transpl 33 2004 823-828
39. R. Comenzo & M.A. Gertz Autologous stem cell transplantation for primary systemic amyloidosis Blood 99 2002 4276-4282
40. W.J. Johnson R.A. Kyle & P.J. Dahlberg Dialysis in the treatment of multiple myeloma Mayo Clin Proc 55 1980 65-72
41. R.A. Kyle M.A. Gertz T.A. Witzig et al. Review of 1027 patients with newly diagnosed multiple myeloma Mayo Clin Proc 78 2003 21-33
42. J. Bladé J.F. San Miguel M. Fontanillas et al. Initial treatment of multiple myeloma: Long-term results in 914 patients Hematol J 2 2001 272-278
43. J. Meharchand Management of hematologic complications of myeloma in: J.S. Malpas D.E. Bergsagel R.A. Kyle & K.C. Anderson (Eds.) Myeloma: Biology and Management 2nd edn 1998 Oxford University Press Oxford 332-357
44. R.T. Means & S.B. Kranz Progress in understanding the pathogenesis of the anemia of chronic disease Blood 80 1992 1639-1647
45. Y. Berguin M. Yerna M. Loo et al. Erythropoiesis in multiple myeloma: defective red cell production Br J Haematol 82 1992 648-653
46. H. Denz D. Fuchs H. Huber et al. Correlation between neopterin, interferon gamma and haemoglobin in patients with haematologic disorders Eur J Haematol 44 1990 186-189
47. W.C. Faquin T.J. Schneider & M.A. Goldberg Effect of inflammatory cytokines on hypoxia-induced erythripoietin production Blood 79 1992 1987-1994
48. M. Tucci D. Grinello P. Cafforio et al. Anemia in multiple myeloma: Role of deregulated plasma cell apoptosis Leuk Lymph 43 2002 1527-1530
49. H. Ludwig E. Fritz H. Kotzman et al. Erythropoietin treatment of anemia associated with multiple myeloma N Engl J Med 322 1990 1693-1699
50. C.S. Cleeland G.D. Demetri J. Claspy et al. Identifying hemoglobin level for optimal quality of life: Results from an incremental analysis J Clin Oncol 8 1999 574a
51. J.D. Rizzo A.E. Lichtin S.H. Woolf et al. Use of epoietin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology Blood 100 2002 2303-2320
52. J.D. Rizzo A.E. Lichtin S.H. Woolf et al. Use of epoietin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and The American Society of Hematology J Clin Oncol 20 2002 40-83
53. H. Ludwig K. Rai J. Bladé et al. Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: Epoetin treatment recommendations Hematol J 3 2001 121-130
54. P.G. Richardson B. Barlogie J. Berenson et al. A phase 2 study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2003 2609-2617
55. D.E. Bergsagel A.J. Bailey G.R. Langley et al. The chemotherapy of plasma cell myeloma and the incidence of acute leukemia N Engl J Med 301 1979 743-748
56. D.E. Bergsagel Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma Hematol Oncol 6 1988 159-166
57. Finnish Leukemia Group Acute leukemia ad other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: A Finnish Leukemia Group Study Eur J Haematol 65 2000 123-127
58. J. Cuzick S. Erskine D. Edelman & D.A.G. Galton A comparison of the incidence of myelodysplastic syndrome and acute myeloid leukemia following melphalan and cyclophosphamide treatment of myelomatosis Br J Cancer 55 1987 53-529
59. C.M. Anderson C.E. Bueno-Ramos S.A. Walner et al. Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: Two cases and an update of the literature Leuk Lymph 32 1999 385-390
60. D.E. Bergsagel Plasma cell neoplasms and acute leukemia Clin Hematol 11 1982 221-234
61. F. Rosner & H.W. Grünwald Simultaneous occurrence of multiple myeloma and acute myeloblastic leukemia: Fact or myth? Am J Med 76 1984 891-899
62. R. Govindarajan S. Jagannath J.T. Flick et al. Preceding standard therapy is the likely cause of MDS after autologous transplantation for multiple myeloma Br J Haematol 95 1996 349-353
63. E.B. Choufani U. Sanchorawala T. Ernst et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations and response to high-dose therapy Blood 97 2001 1885-1887
64. M.A. Dimopoulos A. Anagnostopoulos & D. Weber Treatment of plasma cell dyscrasias with thalidomide and its derivates J Clin Oncol 21 2003 4444-4454
65. M. Zangari B. Barlogie E. Anaissie et al. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: Effects of prophylactic and therapeutic anticoagulation Br J Haematol 126 2004 715-721
66. P. Kelleher H. Chapel Infections: Principles of prevention and therapy in: J. Metha & S. Singhal (Eds.) Myeloma 2002 Martin Dunitz Ltd London 223-239
67. H. Clenchur H.H. Zinneman & W.H. Hall A review of 51 cases of multiple myeloma: Emphasis on pneumonia and other infections as complications Arch Intern Med 103 1959 173-183
68. H.H. Zinneman & W.H. Hall Recurrent pneumonia in multiple myeloma and some observations on immunological response Ann Intern Med 41 1954 1152-1163
69. D.R. Jacobson & S. Zolla-Pazner Immunosupression and infection in multiple myeloma Semin Oncol 13 1986 280-292
70. S. Border R. Humphrey M. Durn et al. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma N Engl J Med 193 1975 887-892
71. J.L. Fahey R. Scoggins J.P. Utz & C.F. Szwed Infection, antibody response and gammaglobulin components in multiple myeloma and macroglobulinemia Am J Med 35 1963 698-707
72. R.M. Hargreaves J.R. Lea H. Griffiths et al. Immunological factors and risk of infection in plateau phase myeloma J Clin Pathol 48 1995 260-266
73. H.G. Mills & J.C. Cawley Abnormal monoclonal antibody-defined helper/ suppressor T-cell subpopulations in multiple myeloma: Relation to treatment and clinical stage Br J Haematol 53 2 1983 271-275
74. B. Cheson R.R. Plass & G. Rothstein Defective opsonization in multiple myeloma Blood 55 1980 602-606
75. E. Kansu E. Akalin C. Civelek et al. Serum bactericidal and opsonic activities in chronic lymphocytic leukemia and multiple myeloma Am J Hematol 23 1986 191-196
76. G. Hopen J. Glette & R. Matre Mechanisms of decreased leukocyte adhesiveness and migration in plasma from patients with IgG myelomatosis Scand J Haematol 32 1984 88-94
77. R.R. MacGregor W.G. Negendank & A.D. Schreiber Impaired granulocyte adherence in multiple myeloma: Relationship to complement system, granulocyte delivery, and infection Blood 51 1978 591-599
78. C. Cesana A.M. Nosari C. Klersy et al. Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules Haematologica 88 2003 1022-1028
79. B. Hoen M. Kessler D. Hestin & D. Mayeux Risk factors for bacterial infections in chronic hemodialysis adult patients: A multicentre prospective survey Nephrol Dial Transplant 10 1995 377-381
80. L. Snowdon J. Gibson & D.E. Joshua Frequency of infection in plateau-phase multiple myeloma (Letter) Lancet 344 1994 262
81. B.R. Meyers S.Z. Hirschman & J.A. Axelrod Current pattern of infection in multiple myeloma Am J Med 52 1972 87-92
82. B.S. Shaikh R.M. Lombard P.C. Appelbaum & M.S. Bentz Changing patterns of infections in patients with multiple myeloma Oncology 39 1982 78-82
83. D.G. Savage J. Lindembaum & T.J. Garret Biphasic pattern of bacterial infection in multiple myeloma Ann Intern Med 96 1982 47-50
84. R.T. Perri R.P. Hebbel & M.M. Oken Influence of treatment and response status on infection in multiple myeloma Am J Med 71 1981 935-940
85. M.A. Gertz M.Q. Lacy & A. Dispenzieri Amyloidosis Hematol Oncol Clin North Am 13 1999 1211-1234
86. M.M. Oken C. Pomeroy & D. Weisdorf Prophylactic antibiotics for the prevention of early infection in multiple myeloma Am J Med 100 1996 624-628
87. H.S. Birgens F. Espersen J.B. Hertz et al. Antibody response to pneumococcal vaccination in patients with myelomatosis Scand J Haematol 30 1983 324-330
88. H.M. Lazarus M. Lederman A. Lubin et al. Pneumococcan vaccination: The response of patients with multiple myeloma Am J Med 69 1980 419-424
89. G.P. Schmith R.P. Smith A.L. Baltch et al. Antibody response to pneumococcal vaccine in patients with multiple myeloma J Infect Dis 143 1981 590-597
90. R.A. Shildt R.R. Rubin G. Schiffman & P. Giolma Polyvalent pneumococcal immunization of patients with plasma cell dyscrasias Cancer 48 1981 1377-1380